Analyst Geulah Livshits works at CHARDAN CAPITAL and is covering the the Healthcare sector with 183 price targets and ratings documented since 2019 spanning on 25 stocks.
Geulah Livshits's average stock forecast success ratio is 27.28% with an average time for price targets to be met of 35.23 days.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics, Inc at 30-May-2023.
Analyst best performing recommendations are on IMNM.
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS, INC) at 6/25/2021. The price target of $130 was fulfilled within 3 days with a profit of $41.17 (46.35%) receiving and performance score of 154.49.
Average potential price target upside
Currently, out of the existing stock ratings of Geulah Livshits - 2 which are a Hold (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
70
$5.37 (8.31%)
55
8 days ago
10/16 (62.5%)
$-14.92 (-15.50%)
133
Sell
42
$-22.63 (-35.01%)
39
19 days ago
0/3 (0%)
$-17.86 (-30.57%)
Buy
70
$5.37 (8.31%)
70
22 days ago
3/8 (37.5%)
$23.62 (41.72%)
116
Hold
64
$-0.63 (-0.97%)
55
22 days ago
6/8 (75%)
$4 (3.89%)
37
Hold
50
$-14.63 (-22.64%)
70
22 days ago
2/6 (33.33%)
$15.64 (27.29%)
19
